BIRC5 and lung adenocarcinoma: However, differing from the traditional view, our results show that the BIRC5 inhibition can mediate apoptosis to pyroptosis via caspase3/GSDME in LUAD; these findings provide a key biomarker and explore new therapeutic targets for lung adenocarcinoma diagnosis and treatment.